Avita Medical achieves more positive ReCell repigmentation results

THE ROADHOUSE PHARMACY: Avita Medical (ASX: AVH) announced new positive results have been obtained in a ReCell® Spray‐on Skin® trial in patients suffering with depigmented skin lesions.

Avita Medical’s lead product, ReCell, a single‐use autologous cell harvesting technology, has been used successfully in place of costly permanent laboratory facilities, which require special licensure, in the treatment of patients with vitiligo or piebaldism.

According to the company’s medical interim CEO Timothy Rooney the results are similar to recent reports by German‐based associate professor Dr Matthias Aust, in that these new results highlight ReCell as an innovative and effective treatment for a large, under‐served population.

“It’s estimated that around one in 200 people will suffer from vitiligo,” Rooney said in the company’s ASX announcement.

“In Europe alone that represents more than 3.7 million patients, which signifies a substantial market opportunity for ReCell,”

ReCell technology works through the delivery of viable, pigment‐producing cells harvested from a piece of the patient’s own normally‐pigmented skin and is administered by spraying the cells onto the affected area.

The study involved 10 patients who participated in a randomised, within‐subject controlled pilot trial facilitated by the Netherlands Institute for Pigment Disorders (Stichting Nederlands Instituut voor Pigmentstoornissen or SNIP).

Albert Wolkerstorfer M.D. from the SNIP, who was the Principal Investigator of the trial and is also affiliated with the University of Amsterdam, said the results of the study were a positive indication ReCell can be used effectively in the treating of patients suffering from Vitiligo and piebaldism disorders.

Avita Medical has approval to market ReCell in Europe, Australia and China.

A complete restructure of the European marketing team was undertaken recently with four new members recruited.

A recruitment program is also underway in Australia to expand the commercialisation and marketing effort outside of Western Australia.

With the addition of these new sales and marketing resources, the team will be focused on delivering the sales tactical plan and marketing strategy, building customer relations and achieving sales momentum.

Website: www.avitamedical.com